【レポートの概要（一部）】
1. Report Overview
1.1 Biobanking for Medicine: World Market Review 2015 and Global Segmentation
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Key Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Biobanking and its Applications
2.1 Defining the Human Tissue Banking Market for the Scope of this Report
2.2 The Stem Cell Banking Market – Our Breakdown
2.3 What is Biobanking?
2.4 Main Features of Biobanks
2.5 What Processes are Involved in Biobanking?
2.6 Classification of Biobanks: Tissue Type, Volunteer Group and Ownership Classification Models
2.6.1 Volunteer Group: General vs. Disease Population
2.6.2 Ownership Structure: Public vs. Private
2.7 The Guidelines and Standards for Biobanking
2.8 Laws and Regulations for Biobank-Based Research
2.8.1 HIPAA Amendments
2.9 Biobanking and the Pharmaceutical Industry
2.9.1 Biobanking in Research, Drug Discovery and Development
2.9.1.1 Biobanking – Facilitates Genetic Epidemiology Studies
2.9.1.2 Novel Drug Discovery through Better Understanding of Disease Pathways
2.9.1.3 Biomarker Discovery in Drug Development
2.9.2 Biobanking for Therapeutic Purposes
2.9.3 Biobanking in Clinical Trials
3. Biobanking for Medicine: World Market 2015 to 2026
3.1 The World Biobanking for Medicine Market in 2015
3.2 Biobanking for Medicine: Research vs. Therapeutics in 2020 and 2026
3.3 World Biobanking for Medicine Market: Overarching Revenue Forecast 2015 to 2026
3.4 Biobanks Stored More Than 1.4 Billion Specimens in 2015
3.5 The Biobanking for Medicine Market by Sector: Grouped Revenue Forecasts 2015 to 2026
3.6 Biobanking for Research: Mostly Non-Profit
3.6.1 Biobanking for Research: Revenue Forecast 2015 to 2026
3.6.2 Driving Forces: Outweighs Restraints on the Biobanking Industry for Research
3.7 Biobanking for Future Therapeutic Use: Is It Too Commercial?
3.7.1 Arguments against Commercial Stem Cell Banking for Therapeutic Uses
3.7.2 Biobanking for Future Therapeutic Use: Revenue Forecast 2015 to 2026
3.7.3 Driving and Restraining Forces Influencing the Biobanking Market for Therapeutic Applications, 2015 to 2026
4. Biobanking for Research Purposes
4.1 Breakdown of Biobanking for Research Market by Tissue Type, 2015
4.2 Biobanking for Research in 2020 and 2026: Comparison by Tissue Type
4.3 Biobanking for Research by Tissue Type: Grouped Revenue Forecasts 2015 to 2026
4.4 How Many Specimens are Biobanked for Research?
4.5 The Human Tissue Banking Market for Research in 2015
4.6 The Human Tissue Banking Market for Research: Revenue Forecast 2015 to 2026
4.7 The Human Tissue Banking Market: Commercial vs. Public Sectors
4.7.1 Commercial Human Tissue Banks: Revenue Forecast 2015 to 2026
4.7.2 Public Sector Human Tissue Banks: Revenue Forecast 2015 to 2026
4.8 The Stem Cell Banking Market for Research in 2015
4.9 The Stem Cell Banking Market for Research: Revenue Forecast 2015 to 2026
4.9.1 R&D- Growing Interest Towards iPSCs
4.10 Banking of Other Biologics Specimens for Research in 2015
4.11 Banking of Other Biologic Specimens for Research: Revenue Forecast 2015 to 2026
5. Stem Cell Banking for Future Therapeutic Use
5.1 Stem Cell Banking for Therapeutic Use in 2015: A Breakdown by Stem Cell Type
5.2 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Comparison of Revenue and Market Share, 2020 and 2026
5.3 Stem Cell Banking for Therapeutic Use by Stem Cell Type: Grouped Revenue Forecasts
5.4 How Many Stem Cells Are Biobanked Each Year?
5.5 The Umbilical Cord Blood Banking Market in 2015
5.5.1 Private vs. Public Cord Blood Banking
5.5.2 Umbilical Cord Blood Banking: The Controversies
5.6 The Umbilical Cord Blood Banking Market: Revenue Forecast 2015 to 2026
5.7 The Adult Stem Cell Banking Market in 2015
5.8 The Adult Stem Cell Banking Market: Revenue Forecast 2015 to 2026
6. Leading National Markets 2015 to 2026
6.1 The Geographical Footprint of Biobanking
6.1.1 Biobanking in Europe: Leading the World with Biobanking Networks and Infrastructure
6.1.2 Biobanks in the US: A Fragmented Picture
6.1.3 Biobanking in Asia: A Region Fast Gaining Prominence
6.2 Biobanking for Medicine: The US Led the Way in 2015
6.3 The Leading National Markets: Grouped Revenue Forecasts 2015 to 2026
6.4 How Will Regional Market Shares Change to 2026?
6.5 The US Biobanking Market 2015 to 2026: Diversifying and Expanding
6.6 The Top European Biobanking Markets 2015 to 2026: Leading the Way in Biobanking Infrastructure
6.6.1 Germany: An Advanced Industry with 74 Biobanks Associated with the BBMRI
6.6.2 France: Restrictions on Private Stem Cell Banking Limit the Market
6.6.3 Italy: Is the Limited Private Stem Cell Banking Market Off-Set by Strong Biobanking Networks for Research?
6.6.4 UK: Limited Presence of Biobanking Networks
6.6.5 Spain: Controversy Between Private and Public Umbilical Cord Blood Banks
6.6.6 The Netherlands is Characterised by Comprehensive Biobanking Networks
6.7 The Japanese Biobanking Market 2015 to 2026: A High Level of Government Investment Drives Growth
6.8 The Biobanking Industry in the BRIC Countries: High Growth and Increasing Market Share between 2015 and 2026
6.8.1 The Chinese Biobanking Market 2015 to 2026: The High Rate of Growth Will Continue
6.8.2 The Indian Biobanking Market 2015 to 2026: Set to Become the Leading Market for Private Stem Cell Banking?
6.8.3 The Brazilian Biobanking Market 2015 to 2026: Will New Regulations Drive or Restrain the Market?
6.8.4 Russia: Ban on the Import and Export of Human Tissue and Genetic Information Restricts the Market, But Can This Be Overcome from 2015 to 2026?
7. Technology for Biobanking: Systems, Software, Consumables and Services Associated with Biobanking
7.1 The Biobanking-Associated Market: Overview
7.2 Systems Technology: Fully Automated Handling
7.2.1 Automated Liquid Handling Systems
7.2.2 Frozen Aliquoting: Patented Technology from CryoXtract
7.2.3 Automated DNA Isolation
7.3 Storage Technology: Sustainability, Easy Sample Tracking, and Added Security
7.3.1 Dry State, Room Temperature Storage Eliminates the Need for Expensive, Energy-Consuming Freezers
7.3.2 Ultra-Low Temperature Freezers: Is Their Use Declining?
7.3.3 Cryopreservation: Mechanical vs. Liquid/ Vapour Phase Nitrogen
7.3.4 Automated Storage and Retrieval Systems: Essential Technology
7.3.5 RFID and Tagging Technology: Advantages over Barcodes
7.4 Software for Biobanks
7.4.1 Laboratory Information Management System (LIMS): Unmet Needs in the Market Remain, Despite Recent Advances
7.4.2 LIMS Functions
7.5 Consumables: High Quality Required for Effective Sample Management
7.5.1 Addressing Sample Storage and Tracking Issues
7.6 Biobanking Services: Storage, Management and Transport of Biologic Samples for a Fee
8. Leading Companies in the Biobanking Market
8.1 The Differing Business Models of Biobanking Companies: Sourcing vs. Storing
8.2 Commercial Biobanks for Research Purposes in 2015
8.2.1 Tissue Solutions: A Virtual Biobank with a Global Presence
8.2.1.1 An Overview of the Products and Services Offered by Tissue Solutions
8.2.1.2 Banked Samples Occur in Many Formats
8.2.1.3 Prospective Tissue Collection for Hard-to-Find Samples
8.2.1.4 Fresh Samples from Surgical Resections are in High Demand
8.2.1.5 Freshly Isolated Human Cells are a Valuable Research Tool
8.2.1.6 FDA/ EMA Panel of Normal Tissues
8.2.1.7 Strengths, Capabilities and the Future Outlook for Tissue Solutions
8.2.2 Asterand Bioscience is now Part of Stemgent
8.2.2.1 Asterand’s Products and Services: XpressBANK, BioSpoke and PhaseZERO
8.2.2.2 The Future Outlook for Asterand
8.2.3 Biopta: Human Tissue Provider Now Acquired by Japanese Company ReproCELL
8.2.3.1 Services from Biopta: A Variety of Lab Services and Fresh Tissue Sample Procurement
8.2.3.2 The First Catalogue of Assays Based on Human Functional Tissues
8.2.3.3 The Future Outlook for Biopta: Fresh Tissue Will Be in Demand
8.2.4 BioServe: One of the World’s Largest Commercial Biorepositories
8.2.4.1 BioServe Offers a Comprehensive List of Services: Biobanking, Sourcing and Preclinical Molecular Services
8.2.4.2 The Future Outlook for BioServe
8.2.5 Coriell Institute for Medical Research: Reportedly the Largest Biobank in the World
8.2.5.1 Features of and Recent Developments at Coriell Biobank
8.2.5.2 Future Outlook for the Coriell Biobank
8.3 Prominent Biobanks for Therapeutic Use in 2015
8.3.1 Cord Blood America: Expansion into the Emerging Markets Apparently Stalled, Strategic Alternatives Being Considered
8.3.2 Cryo-Cell International: The First Private Cord Blood Bank in the Market
8.3.3 Cryo-Save’s Educational Programme Benefits Company’s Growth
8.3.4 China Cord Blood Corp: The Only Cord Blood Bank in China with Multiple Licences Is Under a New Owner
8.3.5 LifebankUSA: Acquisition from Human Longevity Inc Will Potentially Drive Growth
8.3.6 ViaCord: More Blood Units Released for Therapy than Any Other Family Bank
8.3.7 Cord Blood Registry: The World’s Largest Newborn Stem Cell Company Will Be Promoted By New Parent Company
8.3.8 Biogenea Pharmaceuticals: A Comprehensive Offering of Stem Cell Banking Services across the Balkan Peninsula
8.3.9 StemLife is Reportedly Facing Challenges Due to Government Regulations in Malaysia
8.3.10 Future Health Biobank: A Strong Market Presence Owing to International Operations
8.3.11 Caladrius Biosciences (formerly NeoStem): More Focus on Cell Therapy Than Stem Cell Banking
8.3.12 Precious Cells is Well Positioned to Take Advantage of the Growing Demand in India
9. Qualitative Analysis of the Biobanking Market 2015 to 2026
9.1 Industry Trends
9.1.1 The Growing Demand for Biobank Resources for Research
9.1.2 The Establishment of Biobanking Networks
9.1.2.1 BBMRI: The Most Extensive Biobank Network
9.1.3 Virtual Biobanks: Connecting a Fragmented Industry
9.1.4 Commercial Biobanks as Intermediaries: New Resources for Research
9.1.5 Automated Biobanking Has Become Imperative
9.1.6 Increasing Uptake of LIMS
9.1.7 Green Banking – Becoming More Energy Efficient
9.2 The Strengths and Weaknesses of the Biobanking Market in 2015
9.2.1 HBS are Valuable Resources for R&D
9.2.2 Governmental Support for Biobanking Forms a Strength of that Industry
9.2.3 Development of Potential Novel Stem Cell Therapies has Increased Public Awareness of Stem Cell Banking
9.2.4 The Effect of Big Data on Biobanking
9.2.5 Insufficient Accessible Numbers of High Quality Biospecimens
9.2.6 Biobanks are Fragmented and Uncoordinated
9.2.7 Lack of Standardisation is a Weakness of the Industry
9.2.8 Lack of Public Awareness Limits Number of Donors
9.2.9 Lack of Engagement with Public Health Services Limits the Stem Cell Banking Market
9.3 Opportunities and Threats Facing the Biobanking Market, 2015 to 2026
9.3.1 Increasing Use of Biobanked Specimens in Genome-Wide Association Studies (GWAS)
9.3.2 Increasing Demand for Biobanked Samples for Preclinical Research
9.3.3 Biobanking Networks as a Basis for Personalised Medicine
9.3.4 Options for Adult Stem Cell Banking Mean an Increasing Target Population for Private Stem Cell Banks
9.3.5 Even With Governmental Funding, Biobanks Must Become Self-Sufficient to Thrive Long-Term
9.3.6 Public Concerns over Confidentiality and Security Threaten Availability of Donors
9.3.7 Limitations Surrounding Informed Consent
9.4 Social, Technological, Economic and Political Factors (STEP) Influencing the Biobanking Industry, 2015 to 2026
10. Research Interviews
10.1 Mr Veselin D. Stefanov, MBA, General Manager, Fidelis Research, Bulgaria
10.1.1 Fidelis Research – Specialists in Human Tissue Procurement With a Strong Network of Partners
10.1.2 Challenges in Tissue Procurement Stem from a Lack of Legislation
10.1.3 Lack of Standardisation Causing Decreased Demand for Biobanked Tissues
10.1.4 Significant Therapeutic Areas of Demand
10.1.5 Essential Qualities for a Successful Tissue Procurement Service
10.1.6 The Impact of Trends in Biobanking
10.2 Dr Jeanne-Hélène di Donato, 3C-R, France
10.2.1 French Biobanks – a Network of Specialized Biobanks
10.2.2 Biobanking Management –Promoting Scientific Value of Collections
10.2.3 Harmonization – Scientific Valorisation
10.2.4 Bioethical – Diverse Views and Policies on Consent
10.2.5 Broad Consent –Is This the Best Option?
10.2.6 3C-R – Services and Solutions for Biobanks
10.3 Dr Luis Nacul and Dr Eliana Lacerda, UK ME/CFS Biobank Project
10.3.1 UK ME/CFS Biobank – Objectives and Activities
10.3.2 Biobank Resource – Available for External Researchers in August 2015
10.3.3 Main Issue – Sustainability
10.3.4 Unmet Needs – Awareness from Government and General Public
11. Conclusions from Our Research and Analysis
11.1 World Biobanking Market 2015 to 2026: High Revenue Growth Predicted
11.2 Biobanking for Research 2015 to 2026: The Value of Biobanked Specimens is Increasingly Recognised
11.3 Biobanking for Therapeutic Use 2015 to 2026: Rapid Expansion in Adult Stem Cell Banking
11.4 The Leading National Markets: High Sales Growth Worldwide
11.5 Current and Future Trends in Biobanking
11.5.1 Increasing Demand for Biobanked Samples – Increasing Revenue
11.5.2 Improving Biobanking Infrastructure – Growth Driver and a Need for Strategic Planning for Sustainability
11.5.3 Marked Challenges, but Opportunities for Expansion
【レポート販売概要】
■ タイトル：バイオバンクの世界市場予測2016-2026■ 英文：Biobanking Market Forecasts 2016-2026
■ 発行日：2016年4月
■ 調査会社：visiongain
■ 商品コード：VGAIN60628
■ 調査対象地域：グローバル
- 心房細動治療薬の世界市場2015-2019About Atrial Fibrillation According to the NHLBI of the NIH in the US, atrial fibrillation is one of the commonest type of arrhythmia. Atrial fibrillation is similar to another type of arrhythmia of the heart, superventricular tachycardia. The chief difference between these two types of arrhythmia is the consistency of the beats. In superventricular tachycardia, the heart beats are regular and at …
- 塗料保護フィルムの世界市場：製品別（TPU、PVC、ポリエステルPET、ポリエチレン）、用途別（自動車、航空宇宙、船舶）、セグメント予測The global paint protection films market size is projected to reach USD 806.4 Million by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 7.1% during the forecast period. Rising consumer awareness regarding vehicle paint protection against bug splatters, stone chipping, and abrasions is anticipated to fuel the demand for paint protection films. The market is mod …
- 医療産業における認知評価・トレーニングの世界市場予測（～2021年）MarketsandMarkets forecasts the cognitive assessment and training in healthcare market size to grow from USD 962.0 Million in 2016 to USD 4,127.2 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 33.8%. Major factors contributing to the growth of the market include aging global population, increasing awareness about brain fitness, and advancements in technology. These factors will drive …
- 世界の軍事IT、データ、コンピューティング市場（2014-2024）：動向、開発、課題Synopsis This report offers readers insights into technological developments in the Military IT, Data and Computing market, as well as detailed analysis of the changing preferences of military forces around the world. It also identifies the current trends in the changing industry structure and the challenges faced by industry participants. Summary Technological Developments in the global Military …
- 世界の軍事衛星市場2015-2025Summary The Global Military satellite Market2015-2025 report, published by Strategic Defence Intelligence, provides readers with a detailed analysis of both historic and forecast global industry values, factors influencing demand, the challenges faced by industry participants, analysis of industry leading companies, and key news. Key Findings - The globalMilitary satellite marketis expected to be …
- 生物学的製剤API（原薬）製造サービスの世界市場予測2016-2026Biological Drug API Manufacturing Services World Industry and Market Predictions 2016-2026: Mammalian Cell Culture, Microbial Fermentation, Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccine reviews the contract active pharmaceutical ingredient (API) manufacturing market for biologics. This study gives quantitative and qualitative analysis for that overall world market, as …
- 食肉市場：シエラレオネ（～2017）Synopsis "Meat Market in Sierra Leone: Databook to 2017" is the result of Canadean's extensive market research covering the Meat market in Sierra Leone. The report presents detailed historic and forecast data on the Meat consumption trends in Sierra Leone, offering consumption volume and value at market and category level. Bringing together Canadean's research, modeling, and analysis expertise to …
- Warren Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Warren Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Warren Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential sour …
- 航空用レーザー障害物回避モニタリングシステムの世界市場About Airborne Laser Obstacle Avoidance Monitoring Systems Airborne capabilities are determined by the success of pilot's efficiency combined with advanced technologies. Traditionally, radars were used for the safer operation of the fleet by maintaining a safe distance from the ground level and the aircraft trajectory. However, they lacked the angular resolution to detect small, natural, and fabri …
- 環境健康と安全の世界市場分析：製品別（ソフトウェア、ハードウェア）、用途別（医療廃棄物管理、産業廃棄物管理、廃水管理）、エンドユーザー別、セグメント予測、2014-2025The global environmental health and safety market is expected to reach USD 96.18 billion by 2025, according to a new report by Grand View Research, Inc. The increasing number of regulations imposed by environmental protection and governmental agencies worldwide is expected to be one of the major factors driving demand during the forecast period. Economic slowdown in several parts of the globe has …
- Tachycardia (Tachyarrhythmias)：グローバル臨床試験レビューH1, 2013Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2013" provides data on the Tachycardia (Tachyarrhythmias) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tachycardia (Tachyarrhythmias). It includes an o …
- 脊髄損傷治療のグローバル臨床試験動向（2014年下半期）Spinal Cord Injury Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spinal Cord Injury. It includes an overview of the trial numbers and their recruitme …
- Kinetic Concepts, Inc.：市場シェア分析Kinetic Concepts, Inc. Market Share Analysis Summary GlobalData’s new report, “Kinetic Concepts, Inc. Market Share Analysis” provides in-depth information on Kinetic Concepts, Inc’s market position in the different medical equipment markets it operates in. The report provides Kinetic Concepts, Inc market share information in two key market categories – Negative Pressure Wound Therapy (NPWT) and Pr …
- Chevron Corporation：石油・ガスバリューチェーン分析レポート2013Chevron Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Chevron Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Chevron Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 経頭蓋ドプラ法の世界市場2019-2023About this market The advent of robot-assisted transcranial doppler monitoring is likely to push growth in the market. The recent advances in robotics have led to the emergence of robotically driven transcranial doppler examination probes. These devices help obtain uninterrupted and longer transcranial doppler recordings. Technavio’s analysts have predicted that the transcranial doppler market wil …
